Hoya (OTCMKTS:HOCPY) Hits New 12-Month High After Earnings Beat

Shares of Hoya Corp. (OTCMKTS:HOCPYGet Free Report) hit a new 52-week high during trading on Monday following a better than expected earnings announcement. The company traded as high as $165.99 and last traded at $165.99, with a volume of 1788 shares trading hands. The stock had previously closed at $162.55.

The technology company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.10. Hoya had a net margin of 23.33% and a return on equity of 21.15%. The business had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $225.61 billion.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Nomura Securities raised shares of Hoya to a “strong-buy” rating in a research report on Monday, August 18th. The Goldman Sachs Group raised shares of Hoya from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 23rd. Three investment analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat.com, Hoya presently has an average rating of “Strong Buy”.

Read Our Latest Stock Analysis on HOCPY

Hoya Price Performance

The company has a market cap of $55.85 billion, a PE ratio of 39.89, a price-to-earnings-growth ratio of 3.41 and a beta of 1.05. The business’s 50 day moving average price is $143.73 and its 200-day moving average price is $129.71. The company has a quick ratio of 4.46, a current ratio of 5.19 and a debt-to-equity ratio of 0.03.

About Hoya

(Get Free Report)

HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.

Featured Stories

Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.